A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.
Clinical trial NCT06306560 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06306560
- Sponsor
- Harbin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2027-03-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.